A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects
Clinical trial NCT02174510 · COMPLETED
Trial details
- NCT number
- NCT02174510
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-04-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.